Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of faecal microbiota transplantation in patients with acute uncomplicated diverticulitis: study protocol for a randomised placebo-controlled trial.
Thorndal C, Kragsnaes MS, Nilsson AC, Holm DK, dePont Christensen R, Ellingsen T, Kjeldsen J, Bjørsum-Meyer T. Thorndal C, et al. Among authors: holm dk. Therap Adv Gastroenterol. 2025 Jan 2;18:17562848241309868. doi: 10.1177/17562848241309868. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 39758967 Free PMC article.
Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.
Kragsnaes MS, Kjeldsen J, Horn HC, Munk HL, Pedersen FM, Holt HM, Pedersen JK, Holm DK, Glerup H, Andersen V, Fredberg U, Kristiansen K, Christensen R, Ellingsen T. Kragsnaes MS, et al. Among authors: holm dk. BMJ Open. 2018 Apr 27;8(4):e019231. doi: 10.1136/bmjopen-2017-019231. BMJ Open. 2018. PMID: 29703851 Free PMC article.
Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort study.
Novak F, Nilsson AC, Christensen EB, Stougaard CL, Barnkob MB, Holm DK, Witt AH, Byg KE, Johansen IS, Nielsen C, Sejbaek T. Novak F, et al. Among authors: holm dk. Front Immunol. 2024 Sep 5;15:1432348. doi: 10.3389/fimmu.2024.1432348. eCollection 2024. Front Immunol. 2024. PMID: 39301017 Free PMC article.
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.
Novak F, Bajwa HM, Coia JE, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Hvidt MVM, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ Jr, Sejbaek T. Novak F, et al. Among authors: holm dk. J Neurol Neurosurg Psychiatry. 2023 Nov;94(11):934-937. doi: 10.1136/jnnp-2022-330757. Epub 2023 Apr 25. J Neurol Neurosurg Psychiatry. 2023. PMID: 37185261 Free PMC article. Clinical Trial.
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
Erikstrup C, Hother CE, Pedersen OBV, Mølbak K, Skov RL, Holm DK, Sækmose SG, Nilsson AC, Brooks PT, Boldsen JK, Mikkelsen C, Gybel-Brask M, Sørensen E, Dinh KM, Mikkelsen S, Møller BK, Haunstrup T, Harritshøj L, Jensen BA, Hjalgrim H, Lillevang ST, Ullum H. Erikstrup C, et al. Among authors: holm dk. Clin Infect Dis. 2021 Jan 27;72(2):249-253. doi: 10.1093/cid/ciaa849. Clin Infect Dis. 2021. PMID: 33501969 Free PMC article.
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients.
Bajwa HM, Novak F, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Witt AH, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. Bajwa HM, et al. Among authors: holm dk. Mult Scler Relat Disord. 2022 Apr;60:103729. doi: 10.1016/j.msard.2022.103729. Epub 2022 Mar 6. Mult Scler Relat Disord. 2022. PMID: 35334278 Free PMC article.
52 results